Novartis’ Generics Unit Agrees To Pay $195M To Resolve Criminal Charges Over Deals With Other Manufacturers

The payment has come in response to an investigation that has been exploring alleged schemes in which one generic company would decide to raise prices on a particular drug and others would follow suit.

from Kaiser Health News https://ift.tt/2TBD2AW